Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy.

about

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy.

Item

http://www.wikidata.org/entity/Q41974638

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Changes to Intermediary Metabo ...... gnetic Resonance Spectroscopy.

@en

type

Item

label

Changes to Intermediary Metabo ...... gnetic Resonance Spectroscopy.

@en

prefLabel

Changes to Intermediary Metabo ...... gnetic Resonance Spectroscopy.

@en

P1476

Changes to Intermediary Metabo ...... gnetic Resonance Spectroscopy.

@en

P2093

Guro F Giskeødegård

http://www.w3.org/2001/XMLSchema#string

Jan O Aasly

http://www.w3.org/2001/XMLSchema#string

Krisztina K Johansen

http://www.w3.org/2001/XMLSchema#string

Linda R White

http://www.w3.org/2001/XMLSchema#string

Oddbjørn Sæther

http://www.w3.org/2001/XMLSchema#string

Tone F Bathen

http://www.w3.org/2001/XMLSchema#string

P2860

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers

Metabolomic profiling in LRRK2-related Parkinson's disease

The choroid plexuses and the barriers between the blood and the cerebrospinal fluid.

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy.

Effects of dimethyl sulfoxide on the oxidative function of human neutrophils.

Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.

P304

264896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/264896

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281682465

http://www.w3.org/2001/XMLSchema#string

P698

26357583

http://www.w3.org/2001/XMLSchema#string

P932

4556333

http://www.w3.org/2001/XMLSchema#string